ArticleOncotarget2018
BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC.
Toni Jauset et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleOncotarget2018
Toni Jauset et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.